Allergan IUD Gets FDA Nod for Extended Use

August 10, 2017

The FDA approved a supplemental NDA to extend the duration of use for Allergan’s intrauterine device Liletta.

Under the new approval, the levonorgestrel-releasing IUD’s duration of use is extended up to four years. The device was approved in February 2015 and the agency granted it additional approval for a single-handed inserter last January.

Women’s health nonprofit Medicines360, which partnered with Allergan to make the device available, called the approval a major milestone.

View today's stories